CN103946235A - 用于生产因子viii的方法 - Google Patents

用于生产因子viii的方法 Download PDF

Info

Publication number
CN103946235A
CN103946235A CN201280057127.6A CN201280057127A CN103946235A CN 103946235 A CN103946235 A CN 103946235A CN 201280057127 A CN201280057127 A CN 201280057127A CN 103946235 A CN103946235 A CN 103946235A
Authority
CN
China
Prior art keywords
factor
factor viii
cell
polypeptide
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201280057127.6A
Other languages
English (en)
Chinese (zh)
Inventor
L.B.约翰逊
M.P.科林德
P.L.诺拜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of CN103946235A publication Critical patent/CN103946235A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201280057127.6A 2011-11-21 2012-11-02 用于生产因子viii的方法 Withdrawn CN103946235A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11189861.5 2011-11-21
EP11189861 2011-11-21
US201161563188P 2011-11-23 2011-11-23
US61/563,188 2011-11-23
PCT/EP2012/071701 WO2013075926A1 (en) 2011-11-21 2012-11-02 Method for production of factor viii

Publications (1)

Publication Number Publication Date
CN103946235A true CN103946235A (zh) 2014-07-23

Family

ID=48469150

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280057127.6A Withdrawn CN103946235A (zh) 2011-11-21 2012-11-02 用于生产因子viii的方法

Country Status (5)

Country Link
US (1) US20140308707A1 (https=)
EP (1) EP2782929A1 (https=)
JP (1) JP2014533495A (https=)
CN (1) CN103946235A (https=)
WO (1) WO2013075926A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106167527A (zh) * 2016-06-13 2016-11-30 长沙郝怡雅医药科技有限公司 一种融合蛋白

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017118764A1 (en) * 2016-01-07 2017-07-13 Thomas Brocker Novel approaches for the in vivo and in vitro visualization of dying cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060099685A1 (en) * 1999-04-15 2006-05-11 Yallop Christopher A Recombinant expression of factor VIII in human cells
WO2008135501A1 (en) * 2007-05-04 2008-11-13 Novo Nordisk A/S Improvement of factor viii polypeptide titers in cell cultures
CN101473029A (zh) * 2006-04-21 2009-07-01 拜尔健康护理有限责任公司 抗凋亡基因在用于灌注培养的哺乳动物细胞中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237870A1 (en) * 2002-06-07 2003-12-22 The Brigham & Women's Hospital, Inc. Method and composition for inhibing or slowing blood coagulation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060099685A1 (en) * 1999-04-15 2006-05-11 Yallop Christopher A Recombinant expression of factor VIII in human cells
CN101473029A (zh) * 2006-04-21 2009-07-01 拜尔健康护理有限责任公司 抗凋亡基因在用于灌注培养的哺乳动物细胞中的应用
WO2008135501A1 (en) * 2007-05-04 2008-11-13 Novo Nordisk A/S Improvement of factor viii polypeptide titers in cell cultures

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JIALAN SHI ET AL: "Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites", 《BLOOD》 *
MILLE PETERSEN KOLIND ET AL: "Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction", 《JOURNAL OF BIOTECHNOLOGY》 *
MILLE PETERSEN KOLIND ET AL: "Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction", 《JOURNAL OF BIOTECHNOLOGY》, vol. 151, 8 January 2011 (2011-01-08), pages 357 - 362 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106167527A (zh) * 2016-06-13 2016-11-30 长沙郝怡雅医药科技有限公司 一种融合蛋白

Also Published As

Publication number Publication date
EP2782929A1 (en) 2014-10-01
JP2014533495A (ja) 2014-12-15
US20140308707A1 (en) 2014-10-16
WO2013075926A1 (en) 2013-05-30

Similar Documents

Publication Publication Date Title
Rosenberg et al. Intracellular trafficking of factor VIII to von Willebrand factor storage granules.
Rapoport et al. The thyrotropin (TSH)-releasing hormone receptor: interaction with TSH and autoantibodies
US10626431B2 (en) Method for improved isolation of recombinantly produced proteins
Mercado et al. Ca2+-dependent desensitization of TRPV2 channels is mediated by hydrolysis of phosphatidylinositol 4, 5-bisphosphate
Madabhushi et al. von Willebrand factor (VWF) propeptide binding to VWF D′ D3 domain attenuates platelet activation and adhesion
Kamboj et al. Identification of an octapeptide involved in homophilic interaction of the cell adhesion molecule gp80 of Dictyostelium discoideum
RS59833B1 (sr) Sastavi faktora viii i postupci za pravljenje i upotrebu istih
DK2282728T3 (en) Modulation at Vps10p domain receptors
Grogan et al. Synthesis of lipidated green fluorescent protein and its incorporation in supported lipid bilayers
MX2008012167A (es) Antigenos de grupo sanguineo de diferentes tipos para aplicaciones de diagnostico y terapeuticas.
DE102007031708A1 (de) Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
Handin Inherited platelet disorders
Guttman et al. Decoding of Lipoprotein− Receptor Interactions: Properties of Ligand Binding Modules Governing Interactions with Apolipoprotein E
Pennings et al. Platelets express three different splice variants of ApoER2 that are all involved in signaling
Cornish et al. Amylin and adrenomedullin: novel regulators of bone growth
WO2021062263A1 (en) Methods of evaluating polypeptide-modified polymers in compositions
Brueckner et al. Structure of β-adrenergic receptors
White et al. Biological activity, membrane‐targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli
CN103946235A (zh) 用于生产因子viii的方法
Zhao et al. The role of calcium in lipoprotein release by the low-density lipoprotein receptor
Stuart Characterization of a novel insulin receptor from stingray liver.
US20020034802A1 (en) Crystals of the alpha 1 beta 1 integrin I-domain and their use
WO2022225796A1 (en) Phosphatidylserine binding agents for the detection and depletion of phosphatidylserine positive cells
Sawyer et al. Human saposin B ligand binding and presentation to α-galactosidase A
US7763708B2 (en) Methods and compositions for modulating C5-a-mediated inflammatory responses

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20140723